Today: Brokerages gives Consensus Recommendation of “Strong Buy” to H. Lundbeck A/S- (HLUYY)

Today: Brokerages gives Consensus Recommendation of “Strong Buy” to H. Lundbeck A/S- (HLUYY)

H. Lundbeck A/S- (NASDAQ:HLUYY) has been assigned an average broker rating score of 1.00 (Strong Buy) from the one brokers that provide coverage for the stock, Zacks Investment Research reports. One analyst has rated the stock with a strong buy rating.

Zacks has also given H. Lundbeck A/S- an industry rank of 211 out of 265 based on the ratings given to related companies.

A number of equities analysts have issued reports on the stock. Zacks Investment Research cut shares of H. Lundbeck A/S- from a “buy” rating to a “hold” rating in a research report on Friday, July 29th. Deutsche Bank AG cut shares of H. Lundbeck A/S- from a “buy” rating to a “hold” rating in a research report on Wednesday, August 31st.

H. Lundbeck A/S- (NASDAQ:HLUYY) opened at 32.45 on Friday. The company’s 50 day moving average is $36.70 and its 200-day moving average is $37.27. The stock’s market cap is $6.40 billion. H. Lundbeck A/S- has a 52-week low of $28.52 and a 52-week high of $42.17.

About H. Lundbeck A/S-

H Lundbeck A/S is a Denmark-based company active in the pharmaceuticals industry. It is engaged in the research, development, manufacture and marketing of pharmaceuticals for the treatment of brain disorders, such as Alzheimer’s disease, Bipolar disorder, depression, epilepsy, Huntington’s disease, Parkinson’s disease and schizophrenia.

Related posts

Leave a Comment